FEMININE ANTI ITCH CREAM- benzocaine,resorcinol cream

Drug Labeling and Warnings

Drug Details [pdf]

Active ingredients

Benzocaine 20%

Resorcinol 3%

Purpose

External Analgesic

KEEP OUT OF REACH OF CHILDREN

Keep out of reach of children. If swallowed, get medical help or contact a Poison Control Center right away.

INDICATIONS & USAGE

Uses Temporarily relieves itching.

Directions

Adults and children 12 years and older

Apply a fingertip amount, approximately 1 inch strip to affected area not more than 3 to 4 times daily. Clean nozzle of tube by wiping thoroughly before replacing cap. Keep cap tightly closed between uses.

Inactive Ingredients

Inactive ingredient Acrylates (C-10-30)alkyl acrylate crosspolymer, Aloe barbadensis leaf juice, aminomethyl propanol, cetyl alcohol,

Glyceryl stearate, Isopropyl myristate, isopropyl palmitate, lanolin, methylparaben, PEG-100 stearate, Potassium cetyl phosphate, Propylene glycol, Retinyl palmitate, sdium sulfite, tocopheryl acetate, Trisodium HEDTA, vitamin D3, water, Zea mays (corn) oil.

Stop Use and ask Doctor

Stop Use and ask doctor is condition worsens or if symptoms persist for more than 7 days or clear up and occur again within a few days.

Other information

● store at 20° to 25°C ( 68° to 77°F)

.

Warning

For External Use Only

When using avoid contact with eyes.

QUESTIONS

Questions? Call 1-888-296-9067

SPL UNCLASSIFIED SECTION

Distributed by:

Trifecta Pharmaceuticals USA™

101 NE Third Avenue, Suite 1500

Ft. Lauderdale, FL 33301, USA

1-888-296-9067

This product is not manufactured or distributed by Combe Incorporated, owner of the registered trademark Vagasil®

Do Not Use

Do not use this product if youhave a history of allergy to local anesthetics such as procaine, butacaine, benzocaine or other caine anesthetics.

Packagte Label

Package Label

INGREDIENTS AND APPEARANCE

FEMININE ANTI ITCH CREAM 
benzocaine,resorcinol cream

Product Information
Product Type	HUMAN OTC DRUG	Item Code (Source)	NDC: 69396-183
Route of Administration	TOPICAL

Active Ingredient/Active Moiety
Ingredient Name	Basis of Strength	Strength
BENZOCAINE (UNII: U3RSY48JW5) (BENZOCAINE - UNII:U3RSY48JW5)	BENZOCAINE	20 g  in 100 g
RESORCINOL (UNII: YUL4LO94HK) (RESORCINOL - UNII:YUL4LO94HK)	RESORCINOL	3 g  in 100 g

Inactive Ingredients
Ingredient Name	Strength
POTASSIUM CETYL PHOSPHATE (UNII: 03KCY6P7UT)
.ALPHA.-TOCOPHEROL ACETATE (UNII: 9E8X80D2L0)
ZEA MAYS (CORN) OIL (UNII: 8470G57WFM)
METHYLPARABEN (UNII: A2I8C7HI9T)
TRISODIUM HEDTA (UNII: K3E0U7O8KI)
SODIUM SULFATE (UNII: 0YPR65R21J)
ACRYLATES/C10-30 ALKYL ACRYLATE CROSSPOLYMER (60000 MPA.S) (UNII: 8Z5ZAL5H3V)
GLYCERYL STEARATE (UNII: 230OU9XXE4)
LANOLIN (UNII: 7EV65EAW6H)
PROPYLENE GLYCOL (UNII: 6DC9Q167V3)
CETYL ALCOHOL (UNII: 936JST6JCN)
ALOE BARBADENSIS LEAF JUICE (UNII: RUE8E6T4NB)
AMINOMETHYL PROPANOL (UNII: LU49E6626Q)
WATER (UNII: 059QF0KO0R)
RETINYL PALMITATE (UNII: 1D1K0N0VVC)
ISOPROPYL MYRISTATE (UNII: 0RE8K4LNJS)
PEG-100 STEARATE (UNII: YD01N1999R)
ISOPROPYL PALMITATE (UNII: 8CRQ2TH63M)
CHOLECALCIFEROL (UNII: 1C6V77QF41)

Packaging
#	Item Code	Package Description	Marketing Start Date	Marketing End Date
1	NDC: 69396-183-01	1 in 1 BOX	05/01/2026
1		28.4 g in 1 TUBE; Type 0: Not a Combination Product
2	NDC: 69396-183-33	3 in 1 BOX	05/01/2026
2		28.4 g in 1 TUBE; Type 0: Not a Combination Product

Marketing Information
Marketing Category	Application Number or Monograph Citation	Marketing Start Date	Marketing End Date
OTC Monograph Drug	M017	04/30/2026

Labeler - TRIFECTA PHARMACEUTICALS USA LLC (079424163)

Registrant - Trifecta Pharmaceuticals USA (079424163)